Cipla Ltd
₹1311.60
(-1.30)%
Tue, 03 Feb 2026, 02:56 am
Health Technology
Pharmaceuticals: Other
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
105960.63
Net Profit
5291.05
P/B
3.73
Sector P/E
31.51
P/E
22.08
EV/EBITDA
14.53
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
16.31
ROCE (Industry)
15.98
RONW (Industry)
14.01
ROE
18.28
ROCE
23.15
Debt/Equity
0.02
EPS (TTM)
58.86
Dividend Yield
1.22
Book Value
407.52
Interest Cover
111
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (6.4x coverage).
- Dividends after 3 years are expected to be well covered by earnings (6.2x coverage).
- Dividends per share have been stable in the past 10 years.
- Cipla's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Cipla's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Cipla's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Cipla is expected to decrease over the next 2 years.
- Cipla's earnings are expected to grow by 17.6% yearly, however this is not considered high growth (20% yearly).
- Cipla's earnings growth is positive but not above the India market average.
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 29.21 | 29.21 | 29.19 | 29.20 | 29.19 |
| FII | 23.93 | 24.54 | 25.24 | 26.28 | 26.65 |
| DII | 30.72 | 30.25 | 29.26 | 28.15 | 27.71 |
| Public | 16.13 | 15.99 | 16.30 | 16.37 | 16.44 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1897.80 | 1639.80 | 1481.90 | 1381.80 | 1223.90 | 1123.80 | 865.80 |
| Fibonacci | 1639.80 | 1541.24 | 1480.36 | 1381.80 | 1283.24 | 1222.36 | 1123.80 |
| Camarilla | 1394.95 | 1371.30 | 1347.65 | 1381.80 | 1300.35 | 1276.70 | 1253.05 |
Pivots Level: Classic
R3
+516
1897.80
R2
+258
1639.80
R1
+100.10
1481.90
S1
-157.90
1223.90
S2
-258
1123.80
S3
-516
865.80
Moving Average
Period
Value
10-EMA
1343.01
20-EMA
1381.67
30-EMA
1408.82
50-EMA
1442.38
100-EMA
1478.06
200-EMA
1493.59
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 23 Jan 2026 | board-meetings | Quarterly Results | |
| 30 Oct 2025 | board-meetings | Quarterly Results | |
| 13 May 2025 | agm | ||
| 13 May 2025 | dividend | ₹13.00 Dividend /Share | 27 Jun 2025 |
| 10 May 2024 | dividend | ₹13.00 Dividend /Share | 02 Aug 2024 |
| 10 May 2024 | agm | ||
| 11 Jul 2023 | agm | ||
| 11 May 2023 | dividend | ₹8.50 Dividend /Share | 21 Jul 2023 |
| 27 Jul 2022 | agm | ||
| 10 May 2022 | dividend | ₹5.00 Dividend /Share | 10 Aug 2022 |
Peer Comparison
Cipla Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Lupin Ltd
About Cipla Ltd
Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The Company has its wide network of manufacturing, trading and other incidental operations in India and International markets.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1935
Headquarters
CEO
Y K Hamied
Employees
Contact
Website
http://www.cipla.com
cosecretary@cipla.com, contactus@cipla.com
Phone
91-22-24826000
Location
Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra, 400013
cipla ltd History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800